CARE Guidance: Treatment Considerations for Advanced Prostate Cancer


The 2017 CARE™ treatment considerations for advanced prostate cancer, considers updates and experiences of the contributing specialists identified below. Included is a suggested treatment algorithm, along with management considerations for mHSPC, CNSPC/CSPC and CRPC.

This guidance is based on experiences and perspectives of Canadian urologists, medical oncologists and radiation oncologists. The aim of this collaboration is to optimize patient outcomes by taking into account all other specialties who manage and treat patients with advanced prostate cancer.


CARE Faculty Who Have Contributed to This Report:

Dr. Alan So- BC Cancer Agency, Urology, Faculty Lead

Dr. Anil Kapoor- St. Joseph’s Healthcare, Urology

Dr. Brita Danielson- Alberta Health Services, Radiation Oncology, Faculty Lead

Dr. Denis Soulières- Centre hospitalier de l’Université de Montréal, Medical Oncology

Dr. Kim Chi- BCCA, Medical Oncology

Dr. Ricardo Rendon- QEII Health Sciences Centre, Urology

Dr. Sebastien Hotte- Juravinski Cancer Centre, Medical Oncology, Faculty Lead

Dr. Srikala Sridhar- Princess Margaret Cancer Centre, Medical Oncology